Clinical trial
Randomized Open Pilot Study to Evaluate the Efficacy of Subcutaneous Sarilumab in Patients With Moderate-severe COVID-19 Infection
NCT04357808 is registered in ClinicalTrials.gov with Maria del Rosario Garcia de Vicuña Pinedo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Open Pilot Study to Evaluate the Efficacy of Subcutaneous Sarilumab in Patients With Moderate-severe COVID-19 Infection
- Lead sponsor
- Maria del Rosario Garcia de Vicuña Pinedo
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 13, 2020
- Completion date
- December 4, 2020
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.